Supportive Care in Cancer

, Volume 24, Issue 4, pp 1497–1506 | Cite as

Dental abnormalities after chemotherapy in long-term survivors of childhood acute lymphoblastic leukemia 7–40 years after diagnosis

  • Petter Wilberg
  • Adriani Kanellopoulos
  • Ellen Ruud
  • Marianne Jensen Hjermstad
  • Sophie Dorothea Fosså
  • Bente Brokstad Herlofson
Original Article

Abstract

Purpose

Factors associated with the long-term dental effects after chemotherapy for childhood malignancies have not been well described. The primary aims of this study were as follows: (1) to assess whether age at diagnosis and treatment-related factors are associated with dental defects in survivors of childhood acute lymphoblastic leukemia (ALL) and (2) to assess the survivors’ annual expenses for dental treatment compared to reference data.

Methods

This cross-sectional study enrolled 111 Norwegian survivors of ALL diagnosed before the age of 16. All of the subjects completed a questionnaire and underwent medical and oral examinations. Dental defects were registered according to the individual defect index, with 0 = no defects and 140 = anodontia, and the caries experience was registered according to the decayed-missing-filled teeth index (DMFT). Age-matched reference data were drawn from a national general population survey (n = 555).

Results

The mean age at examination was 29.1 years (SD 7.2), and mean follow-up period was 22.9 years (SD 7.3). In a regression model, diagnoses occurring at ≤5 years of age (B = −9.6, p < 0.001) and a cumulative dose of anthracyclines >120 mg/m2 (B = 11.5, p < 0.001) were strongly associated with more severe dental defects. Survivors treated after the age of 5 had experienced more caries than those treated at a younger age [DMFT 9.6 (SD 6.1) vs. 6.0 (SD 4.6), respectively; p = 0.001]. High annual expenses for dental treatment were reported by a larger percentage of the reference population compared to the survivor group (18 vs. 9 %, respectively; p = 0.02).

Conclusions

The age at diagnosis and the dose of anthracyclines appear to be strongly associated with the severity of dental defects, although few survivors reported high annual expenses for dental treatment. The increased risk of dental defects during adulthood should be communicated to ALL survivors.

Keywords

Acute lymphoblastic leukemia Long-term survivors Tooth abnormalities Health care costs Dental caries 

Notes

Acknowledgments

We would like to thank Julie Brandvik, DDS, and Betina Adriana Lind van Pelt, DDS, for measuring the roots and crowns of all the teeth; Dr. Med. Alv A. Dahl, MD, Anna-Marie Thorndall Ryenbakken, and Bernward Zeller, MD, PhD, for their practical help during and after the study period; and Dr. Philos Leiv Sandvik for his assistance with the statistical analysis.

This study received financial support from the Norwegian Cancer Society (grant numbers 59030001 and 59032001) and from Helse SørØst HF (grant number 2009016). We thank these institutions for their gracious support of our research.

Some of the data applied in the analysis of this publication are based on “Level of living 2008 - Cross sectional study – Health.” This survey was financed by the Norwegian Directorate of Health, University of Oslo; Ministry of Children and Equality; the National Centre for Documentation on Disability; and the National Research Center in Complementary and Alternative Medicine. The data were provided by Statistics Norway and prepared and made available by the Norwegian Social Science Data Services (NSD). Statistics Norway, the Norwegian Directorate of Health, the University of Oslo, the Ministry of Children and Equality, the National Centre for Documentation on Disability, The National Research Center in Complementary and Alternative Medicine and NSD are not responsible for the analysis and interpretation of the data presented here.

Conflict of interest

The authors declare that they have no competing interests.

References

  1. 1.
    Cancer Registry of Norway (2014) Cancer in Norway 2012—cancer incidence, mortality, survival and prevalence in Norway. Cancer Registry of Norway, OsloGoogle Scholar
  2. 2.
    Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Mäkipernaa A, Nygaard R, Saarinen-Pihkala UM, on behalf of the Nordic Society of Pediatric Haematology and Oncology (NOPHO) (2000) Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia 14:2267–2275. doi: 10.1038/sj.leu.2401961 CrossRefPubMedGoogle Scholar
  3. 3.
    Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour B, Mallone S, Marcos-Gragera R, Minicozzi P, Sánchez-Pérez MJ, Sant M, Santaquilani M, Stiller C, Tavilla A, Trama A, Visser O, Peris-Bonet R (2014) Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol 15:35–47. doi: 10.1016/s1470-2045(13)70548-5 CrossRefPubMedGoogle Scholar
  4. 4.
    Welbury RR, Craft AW, Murray JJ, Kernahan J (1984) Dental health of survivors of malignant disease. Arch Dis Child 59:1186–1187. doi: 10.1136/adc.59.12.1186 PubMedCentralCrossRefPubMedGoogle Scholar
  5. 5.
    Dahllöf G, Barr M, Bolme P, Modéer T, Lönnqvist B, Ringdèn O, Heimdahl A (1988) Disturbances in dental development after total body irradiation in bone marrow transplant recipients. Oral Surg Oral Med Oral Pathol 65:41–44. doi: 10.1016/0030-4220(88)90189-2 CrossRefPubMedGoogle Scholar
  6. 6.
    Sonis AL, Tarbell N, Valachovic RW, Gelber R, Schwenn M, Sallan S (1990) Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities. Cancer 66:2645–2652. doi: 10.1002/1097-0142(19901215)66:12<2645::aid-cncr2820661230>3.0.co;2-s CrossRefPubMedGoogle Scholar
  7. 7.
    Kaste SC, Hopkins KP, Jones D, Crom D, Greenwald CA, Santana VM (1997) Dental abnormalities in children treated for acute lymphoblastic leukemia. Leukemia 11:792–796. doi: 10.1038/sj.leu.2400670 CrossRefPubMedGoogle Scholar
  8. 8.
    Gawade PL, Hudson MM, Kaste SC, Neglia JP, Constine LS, Robison LL, Ness KK (2014) A systematic review of dental late effects in survivors of childhood cancer. Pediatr Blood Cancer 61:407–416. doi: 10.1002/pbc.24842 PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Effinger KE, Migliorati CA, Hudson MM, McMullen KP, Kaste SC, Ruble K, Guilcher GM, Shah AJ, Castellino SM (2014) Oral and dental late effects in survivors of childhood cancer: a children’s oncology group report. Support Care Cancer. 22:2009–2019. doi: 10.1007/s00520-014-2260-x PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Hölttä P, Hovi L, Saarinen-Pihkala UM, Peltola J, Alaluusua S (2005) Disturbed root development of permanent teeth after pediatric stem cell transplantation—dental root development after SCT. Cancer 103:1484–1493. doi: 10.1002/cncr.20967 CrossRefPubMedGoogle Scholar
  11. 11.
    van der Pas-van Voskuilen IGM, Veerkamp JS, Raber-Durlacher JE, Bresters D, van Wijk AJ, Barasch A, McNeal S, Gortzak RA (2009) Long-term adverse effects of hematopoietic stem cell transplantation on dental development in children. Support Care Cancer 17:1169–1175. doi: 10.1007/s00520-008-0567-1 CrossRefPubMedGoogle Scholar
  12. 12.
    Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Peltola J, Hovi L (2005) Agenesis and microdontia of permanent teeth as late adverse effects after stem cell transplantation in young children. Cancer 103:181–190. doi: 10.1002/cncr.20762 CrossRefPubMedGoogle Scholar
  13. 13.
    Hölttä P (2005) Developmental aberrations of permanent teeth after high-dose anticancer therapy in childhood. A study on stem cell transplant recipients. Dissertation. University of Helsinki, Finland. http://ethesis.helsinki.fi/julkaisut/laa/hamma/vk/holtta/developm.pdf.
  14. 14.
    Dahllöf G, Bågesund M, Ringdén O (1997) Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study. Bone Marrow Transplant 20:479–483. doi: 10.1038/sj.bmt.1700919 CrossRefPubMedGoogle Scholar
  15. 15.
    Hsieh SG, Hibbert S, Shaw P, Ahern V, Arora M (2011) Association of cyclophosphamide use with dental developmental defects and salivary gland dysfunction in recipients of childhood antineoplastic therapy. Cancer 117:2219–2227. doi: 10.1002/cncr.25704 CrossRefPubMedGoogle Scholar
  16. 16.
    Kaste SC, Goodman P, Leisenring W, Stovall M, Hayashi RJ, Yeazel M, Beiraghi S, Hudson MM, Sklar CA, Robison LL, Baker KS (2009) Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115:5817–5827. doi: 10.1002/cncr.24670 PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Marec-Berard P, Azzi D, Chaux-Bodard AG, Lagrange H, Gourmet R, Bergeron C (2005) Long-term effects of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hematol Oncol 22:581–588. doi: 10.1080/08880010500198848 CrossRefPubMedGoogle Scholar
  18. 18.
    Dahl JE (1985) Immediate and delayed effects of repeated doxorubicin injections on rat incisor mesenchymal cells. Acta Odontol Scand 43:155–162. doi: 10.3109/00016358509064146 CrossRefPubMedGoogle Scholar
  19. 19.
    Satoh H, Uesugi Y, Kawabata T, Mori K, Fujii F, Kashimoto Y, Kajimura T, Furuhama K (2001) Morphological classification of dental lesions induced by various antitumor drugs in mice. Toxicol Pathol 29:292–299. doi: 10.1080/019262301316905246 CrossRefPubMedGoogle Scholar
  20. 20.
    Wogelius P, Dahllöf G, Gorst-Rasmussen A, Sørensen HT, Rosthøj S, Poulsen S (2008) A population-based observational study of dental caries among survivors of childhood cancer. Pediatr Blood Cancer 50:1221–1226. doi: 10.1002/pbc.21464 CrossRefPubMedGoogle Scholar
  21. 21.
    Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjønnfjord GE, Fosså SD (2012) Patient knowledge of late effects of acute lymphoblastic leukaemia. Tidsskr Nor Laegeforen 132:2052–2055. doi: 10.4045/tidsskr.12.0153 CrossRefPubMedGoogle Scholar
  22. 22.
    Zeller B, Tamnes CK, Kanellopoulos A, Amlien IK, Andersson S, Due-Tønnessen P, Fjell AM, Walhovd KB, Westlye LT, Ruud E (2013) Reduced neuroanatomic volumes in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2078–2085. doi: 10.1200/JCO.2012.47.4031 CrossRefPubMedGoogle Scholar
  23. 23.
    Kanellopoulos A, Hamre HM, Dahl AA, Fosså SD, Ruud E (2013) Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma. Pediatr Blood Cancer 60:849–855. doi: 10.1002/pbc.24375 CrossRefPubMedGoogle Scholar
  24. 24.
    Hamre HM, Zeller B, Kanellopoulos A, Ruud E, Fosså SD, Loge JH, Aukrust P, Halvorsen B, Mollnes TE, Kiserud CE (2013) Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun 30:80–87. doi: 10.1016/j.bbi.2013.01.006 CrossRefPubMedGoogle Scholar
  25. 25.
    Zeller B, Ruud E, Loge JH, Kanellopoulos A, Hamre H, Godang K, Wyller VB (2014) Chronic fatigue in adult survivors of childhood cancer: associated symptoms, neuroendocrine markers, and autonomic cardiovascular responses. Psychosomatics 55:621–629. doi: 10.1016/j.psym.2013.12.005 CrossRefPubMedGoogle Scholar
  26. 26.
    Statistics Norway (2009) Samordnet levekårsundersøkelse 2008 - tverrsnittsundersøkelsen. Dokumentasjonsrapport. 2009; Notater: 2009/40. http://www.ssb.no/a/publikasjoner/pdf/notat_200940/notat_200940.pdf. Accessed 17 April 2015
  27. 27.
    Statistics Norway (2010) Tannhelse: Personell og kostnader, tannhelsetilstand og tannlegebesøk. 2010; Rapporter: 29/2010. http://www.ssb.no/a/publikasjoner/pdf/rapp_201029/rapp_201029.pdf. Accessed 17 April 2015
  28. 28.
    Moe P, Seip M, Finne P, Kolmannskog S (1984) Intermediate dose methotrexate in childhood acute lymphocytic leukemia. Pediatr Hematol Oncol 1:113–118. doi: 10.3109/08880018409141718 Google Scholar
  29. 29.
    Vaitkeviciene G, Forestier E, Hellebostad M, Heyman M, Jonsson OG, Lahteenmaki PM, Rosthoej S, Soderhall S, Schmiegelow K (2011) High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Eur J Haematol 86:38–46. doi: 10.1111/j.1600-0609.2010.01522.x CrossRefPubMedGoogle Scholar
  30. 30.
    Knutson JW (1944) An index of the prevalence of dental caries in schoolchildren. Public Health Rep 59:253–263. doi: 10.2307/4584789 CrossRefGoogle Scholar
  31. 31.
    World Health Organization (1997) Oral health surveys: basic methods, 4th ed. World Health Organization, Geneva. http://new.paho.org/hq/dmdocuments/2009/OH_st_Esurv.pdf. Accessed 17 April 2015
  32. 32.
    Löe H (1967) The gingival index, the plaque index, and the retention index systems. J Periodontol 38:610–616. doi: 10.1902/jop.1967.38.6.610 CrossRefPubMedGoogle Scholar
  33. 33.
    Lind V (1972) Short root anomaly. Scand J Dent Res 80:85–93. doi: 10.1111/j.1600-0722.1972.tb00268.x PubMedGoogle Scholar
  34. 34.
    Hölttä P, Nyström M, Evälahti M, Alaluusua S (2004) Root-crown ratios of permanent teeth in a healthy Finnish population assessed from panoramic radiographs. Eur J Orthod 26:491–497. doi: 10.1093/ejo/26.5.491 CrossRefPubMedGoogle Scholar
  35. 35.
    Hölttä P, Alaluusua S, Saarinen-Pihkala UM, Wolf J, Nystrom M, Hovi L (2002) Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant 29:121–127. doi: 10.1038/sj.bmt.1703330 CrossRefPubMedGoogle Scholar
  36. 36.
    de Vet HCW, Terwee CB, Knol DL, Bouter LM (2006) When to use agreement versus reliability measures. J Clin Epidemiol 59:1033–1039. doi: 10.1016/j.jclinepi.2005.10.015 CrossRefPubMedGoogle Scholar
  37. 37.
    Brook AH (1984) A unifying aetiological explanation for anomalies of human tooth number and size. Arch Oral Biol 29:373–378. doi: 10.1016/0003-9969(84)90163-8 CrossRefPubMedGoogle Scholar
  38. 38.
    Maciel JC, de Castro CG, Jr BAL, Di Leone LP, da Silveira HE (2009) Oral health and dental anomalies in patients treated for leukemia in childhood and adolescence. Pediatr Blood Cancer 53:361–365. doi: 10.1002/pbc.22108 CrossRefPubMedGoogle Scholar
  39. 39.
    Haavikko K (1970) The formation and the alveolar and clinical eruption of the permanent teeth. An orthopantomographic study. Suom Hammaslääk Toim 66:103–170PubMedGoogle Scholar
  40. 40.
    Nordgarden H, Jensen JL, Storhaug K (2002) Reported prevalence of congenitally missing teeth in two Norwegian counties. Community Dent Health 19:258–261PubMedGoogle Scholar
  41. 41.
    Patton LL, White BA, Field MJ (2001) Extending Medicare coverage to medically necessary dental care. J Am Dent Assoc 132:1294–1299. doi: 10.14219/jada.archive.2001.0376 CrossRefPubMedGoogle Scholar
  42. 42.
    Jensen SB, Pedersen AML, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NNF, Mello ALS, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FKL, Brennan MT (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18:1061–1079. doi: 10.1007/s00520-010-0837-6 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Petter Wilberg
    • 1
  • Adriani Kanellopoulos
    • 2
    • 3
  • Ellen Ruud
    • 2
  • Marianne Jensen Hjermstad
    • 4
    • 5
  • Sophie Dorothea Fosså
    • 6
  • Bente Brokstad Herlofson
    • 1
  1. 1.Department of Oral Surgery and Oral Medicine, Faculty of DentistryUniversity of OsloOsloNorway
  2. 2.Department of Paediatric Medicine, Women and Children’s DivisionOslo University Hospital, RikshospitaletOsloNorway
  3. 3.Faculty of MedicineUniversity of OsloOsloNorway
  4. 4.Regional Centre for Excellence in Palliative Care, Department of OncologyOslo University Hospital, UllevålOsloNorway
  5. 5.European Palliative Care Research Centre, Faculty of Medicine, Department of Cancer Research and Molecular MedicineNorwegian University of Science and TechnologyTrondheimNorway
  6. 6.National Resource Centre for Late Effects After Cancer Treatment, Department of OncologyOslo University Hospital, RadiumhospitaletOsloNorway

Personalised recommendations